Search
for
Sort by
Research 361–390 of 881
- The Rise of Acellular Regenerative Aesthetics: Are Exosomes Replacing Stem Cells?
- A RANDOMIZED, PROSPECTIVE, SINGLE-BLIND CLINICAL TRIAL: COMPARATIVE STUDY OF COMPARING THE EFFICACY AND SAFETY OF DIFFERENT MINOXIDIL FORMULATIONS IN TREATING ANDROGENIC ALOPECIA
- A Study on the Clinical, Hormonal and Gynecological Parameters in Polycystic Ovarian Syndrome
- A Comparative Study of Phytochemistry and Pharmacological Attributes of <i>Musa sapientum</i> and <i>Musa paradisiaca</i>
- UTILIZING ULTRASOUND FOR GENE THERAPY:A PROMISING STRATEGY FOR TISSUE REGENERATION
- Efficacy of 5% Minoxidil Versus Platelet Rich Plasma in Treatment of Alopecia Areata
- Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
- Co-existence of Systemic Lupus Erythematosus and Celiac Disease: A Case Report
- Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2
- FREQUENCY OF SKIN MANIFESTATIONS IN PATIENTS ON CHEMOTHERAPY
- Acute post-operative edema. A major morbidity after hair transplant.
- Efficacy of Autologous Platelet Rich Plasma in the Treatment of Male Androgenetic Alopecia
- Recent Advances in Biopolymeric Composite Materials for Tissue Engineering and Regenerative Medicines: A Review
- An Algorithm for Reconstruction of Electrical Injuries of the Scalp
- Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
- Nanoparticles in Cancer Treatment: A Narrative Review
- 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial
- Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Patterns of Common Dermatological Conditions among Children and Adolescents in Pakistan
- [Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition].
- 74643 Deuruxolitinib improves scalp hair regrowth over time in patients with severe alopecia areata: Pooled analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials
- A novel finding of hair growth like vellus hairs on glabrous skin of distal phalanx of thumb in Vogt–Koyanagi–Harada disease: A case report
- 62339 Improvement in anxiety and depression in adult patients with severe alopecia areata treated with deuruxolitinib: Pooled data from the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- 60058 Change in patient-reported hair satisfaction during deuruxolitinib treatment of severe alopecia areata: Pooled data from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Comparison of Therapeutic Efficacy of Topical Tacrolimus 0.1% and Topical Dithranol 0.5% in Treatment of Alopecia Areata
- Comparing the Efficacy of Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata
- Effectiveness and Safety Profile of Cisplatin Versus Nab-Paclitaxel Concomitant Chemoradiotherapy in Postoperative Early-Stage Cancer of Cervix